ArticleACS central science2021

Engineered Ribosyl-1-Kinase Enables Concise Synthesis of Molnupiravir, an Antiviral for COVID-19.

John A McIntosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.